Aromatase is phosphorylated in situ at serine-118

Journal of Steroid Biochemistry and Molecular Biology

Volumn 112, Issue 1-3, 2008, Pages 95-101

  Miller, Todd W ^a   Shin, Incheol ^a,b   Kagawa, Norio ^a   Evans, Dean B ^c   Waterman, Michael R ^a   Arteaga, Carlos L ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b Hanyang University   (South Korea)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aromatase; Estrogen synthase; Phosphorylation; Post translational modification

Indexed keywords

ALANINE; AROMATASE; ASPARTIC ACID; SERINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMAL CELL; NONHUMAN;

ANIMALS; AROMATASE; CELL LINE; CERCOPITHECUS AETHIOPS; ENZYME ACTIVATION; HUMANS; MICE; MUTATION; PHOSPHORYLATION; SERINE;

ANIMALIA; MAMMALIA;

EID: 55349119474     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.09.001     Document Type: Article

References (41)

1. Bulun S.E., Sebastian S., Takayama K., Suzuki T., Sasano H., and Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J. Steroid Biochem. Mol. Biol. 86 (2003) 219-224
2. Bulun S.E., Noble L.S., Takayama K., Michael M.D., Agarwal V., Fisher C., Zhao Y., Hinshelwood M.M., Ito Y., and Simpson E.R. Endocrine disorders associated with inappropriately high aromatase expression. J. Steroid Biochem. Mol. Biol. 61 (1997) 133-139
3. Brueggemeier R.W., Quinn A.L., Parrett M.L., Joarder F.S., Harris R.E., and Robertson F.M. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett. 140 (1999) 27-35
4. Egan K.M., Lawson J.A., Fries S., Koller B., Rader D.J., Smyth E.M., and Fitzgerald G.A. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306 (2004) 1954-1957
5. Zhao Y., Agarwal V.R., Mendelson C.R., and Simpson E.R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137 (1996) 5739-5742
6. Ryde C.M., Nicholls J.E., and Dowsett M. Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines. Cancer Res. 52 (1992) 1411-1415
7. Richards J.A., Petrel T.A., and Brueggemeier R.W. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J. Steroid Biochem. Mol. Biol. 80 (2002) 203-212
8. Mendelson C.R., Corbin C.J., Smith M.E., Smith J., and Simpson E.R. Growth factors suppress and phorbol esters potentiate the action of dibutyryl adenosine 3′,5′-monophosphate to stimulate aromatase activity of human adipose stromal cells. Endocrinology 118 (1986) 968-973
9. Kinoshita Y., and Chen S. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Res. 63 (2003) 3546-3555
10. Shozu M., Sumitani H., Murakami K., Segawa T., Yang H.J., and Inoue M. Regulation of aromatase activity in bone-derived cells: possible role of mitogen-activated protein kinase. J. Steroid Biochem. Mol. Biol. 79 (2001) 61-65
11. Yue W., Wang J.P., Conaway M.R., Li Y., and Santen R.J. Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways. J. Steroid Biochem. Mol. Biol. 86 (2003) 265-274
12. Balthazart J., Baillien M., Charlier T.D., Cornil C.A., and Ball G.F. Multiple mechanisms control brain aromatase activity at the genomic and non-genomic level. J. Steroid Biochem. Mol. Biol. 86 (2003) 367-379
13. Jo Corbin C., Mapes S.M., Lee Y.M., and Conley A.J. Structural and functional differences among purified recombinant mammalian aromatases: glycosylation, N-terminal sequence and kinetic analysis of human, bovine and the porcine placental and gonadal isozymes. Mol. Cell Endocrinol. 206 (2003) 147-157
14. Moslemi S., Vibet A., Papadopoulos V., Camoin L., Silberzahn P., and Gaillard J.L. Purification and characterization of equine testicular cytochrome P-450 aromatase: comparison with the human enzyme. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 118 (1997) 217-227
15. Sethumadhavan K., Bellino F.L., and Thotakura N.R. Estrogen synthetase (aromatase). The cytochrome P-450 component of the human placental enzyme is a glycoprotein. Mol. Cell Endocrinol. 78 (1991) 25-32
16. Balthazart J., and Ball G.F. Is brain estradiol a hormone or a neurotransmitter?. Trends Neurosci. 29 (2006) 241-249
17. Balthazart J., Baillien M., Charlier T.D., and Ball G.F. Calcium-dependent phosphorylation processes control brain aromatase in quail. Eur. J. Neurosci. 17 (2003) 1591-1606
18. Tekmal R.R., Ramachandra N., Gubba S., Durgam V.R., Mantione J., Toda K., Shizuta Y., and Dillehay D.L. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res. 56 (1996) 3180-3185
19. Sasano H., Anderson T.J., Silverberg S.G., Santen R.J., Conway M., Edwards D.P., Krause A., Bhatnagar A.S., Evans D.B., and Miller W.R. The validation of new aromatase monoclonal antibodies for immunohistochemistry-a correlation with biochemical activities in 46 cases of breast cancer. J. Steroid Biochem. Mol. Biol. 95 (2005) 35-39
20. van der Geer P., and Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin-layer cellulose plates. Electrophoresis 15 (1994) 544-554
21. Melsenhelder J., Hunter T., and van der Geer P. Phosphopeptide mapping and identification of phosphorylation sites. In: Ausubel F.M.e.a. (Ed). Current Protocols in Molecular Biology (1999), John Wiley & Sons, Hoboken, NJ pp. 18.9.1-18.9.28
22. Blom N., Sicheritz-Ponten T., Gupta R., Gammeltoft S., and Brunak S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4 (2004) 1633-1649
23. Blom N., Gammeltoft S., and Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294 (1999) 1351-1362
24. Thompson Jr. E.A., and Siiteri P.K. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J. Biol. Chem. 249 (1974) 5364-5372
25. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
26. Kagawa N., Hori H., Waterman M.R., and Yoshioka S. Characterization of stable human aromatase expressed in E. coli. Steroids 69 (2004) 235-243
27. Kagawa N., Cao Q., and Kusano K. Expression of human aromatase (CYP19) in Escherichia coli by N-terminal replacement and induction of cold stress response. Steroids 68 (2003) 205-209
28. Tosha T., Kagawa N., Ohta T., Yoshioka S., Waterman M.R., and Kitagawa T. Raman evidence for specific substrate-induced structural changes in the heme pocket of human cytochrome P450 aromatase during the three consecutive oxygen activation steps. Biochemistry 45 (2006) 5631-5640
29. Aguiar M., Masse R., and Gibbs B.F. Regulation of cytochrome P450 by posttranslational modification. Drug Metab. Rev. 37 (2005) 379-404
30. Oesch-Bartlomowicz B., and Oesch F. Cytochrome-P450 phosphorylation as a functional switch. Arch. Biochem. Biophys. 409 (2003) 228-234
31. McEwen B.S. Invited review. Estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 91 (2001) 2785-2801
32. Taziaux M., Keller M., Bakker J., and Balthazart J. Sexual behavior activity tracks rapid changes in brain estrogen concentrations. J. Neurosci. 27 (2007) 6563-6572
33. Hisamoto K., Ohmichi M., Kurachi H., Hayakawa J., Kanda Y., Nishio Y., Adachi K., Tasaka K., Miyoshi E., Fujiwara N., Taniguchi N., and Murata Y. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem. 276 (2001) 3459-3467
34. Simoncini T., Mannella P., Fornari L., Caruso A., Varone G., and Genazzani A.R. Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 69 (2004) 537-542
35. Wang X., and Chen S. Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor. Cancer Res. 66 (2006) 10281-10286
36. Karkola S., Holtje H.D., and Wahala K. A three-dimensional model of CYP19 aromatase for structure-based drug design. J. Steroid Biochem. Mol. Biol. 105 (2007) 63-70
37. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem. 267 (1992) 83-90
38. Amarneh B., Corbin C.J., Peterson J.A., Simpson E.R., and Graham-Lorence S. Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis. Mol. Endocrinol. 7 (1993) 1617-1624
39. Conley A., and Hinshelwood M. Mammalian aromatases. Reproduction 121 (2001) 685-695
40. Moriarty K., Kim K.H., and Bender J.R. Mini review: estrogen receptor-mediated rapid signaling. Endocrinology 147 (2006) 5557-5563
41. Ronnekleiv O.K., Malyala A., and Kelly M.J. Membrane-initiated signaling of estrogen in the brain. Semin. Reprod. Med. 25 (2007) 165-177